1. Home
  2. OCGN vs AMPY Comparison

OCGN vs AMPY Comparison

Compare OCGN & AMPY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OCGN
  • AMPY
  • Stock Information
  • Founded
  • OCGN 2013
  • AMPY 2011
  • Country
  • OCGN United States
  • AMPY United States
  • Employees
  • OCGN N/A
  • AMPY N/A
  • Industry
  • OCGN Biotechnology: Biological Products (No Diagnostic Substances)
  • AMPY Oil & Gas Production
  • Sector
  • OCGN Health Care
  • AMPY Energy
  • Exchange
  • OCGN Nasdaq
  • AMPY Nasdaq
  • Market Cap
  • OCGN 189.6M
  • AMPY 157.7M
  • IPO Year
  • OCGN N/A
  • AMPY 2011
  • Fundamental
  • Price
  • OCGN $0.70
  • AMPY $3.79
  • Analyst Decision
  • OCGN Strong Buy
  • AMPY Strong Buy
  • Analyst Count
  • OCGN 3
  • AMPY 3
  • Target Price
  • OCGN $6.33
  • AMPY $10.00
  • AVG Volume (30 Days)
  • OCGN 4.2M
  • AMPY 580.6K
  • Earning Date
  • OCGN 03-05-2025
  • AMPY 03-05-2025
  • Dividend Yield
  • OCGN N/A
  • AMPY N/A
  • EPS Growth
  • OCGN N/A
  • AMPY N/A
  • EPS
  • OCGN N/A
  • AMPY 0.31
  • Revenue
  • OCGN $4,054,999.00
  • AMPY $294,680,100.00
  • Revenue This Year
  • OCGN N/A
  • AMPY $26.99
  • Revenue Next Year
  • OCGN N/A
  • AMPY $21.93
  • P/E Ratio
  • OCGN N/A
  • AMPY $12.21
  • Revenue Growth
  • OCGN N/A
  • AMPY 1.72
  • 52 Week Low
  • OCGN $0.52
  • AMPY $3.54
  • 52 Week High
  • OCGN $2.08
  • AMPY $8.15
  • Technical
  • Relative Strength Index (RSI)
  • OCGN 53.03
  • AMPY 35.80
  • Support Level
  • OCGN $0.69
  • AMPY $3.72
  • Resistance Level
  • OCGN $0.80
  • AMPY $4.06
  • Average True Range (ATR)
  • OCGN 0.05
  • AMPY 0.18
  • MACD
  • OCGN 0.02
  • AMPY 0.05
  • Stochastic Oscillator
  • OCGN 58.35
  • AMPY 18.75

About OCGN Ocugen Inc.

Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").

About AMPY Amplify Energy Corp.

Amplify Energy Corp is an independent oil and natural gas company engaged in the acquisition, development, exploitation, and production of oil and natural gas properties in the United States. The company's oil and natural gas properties are located in large, mature oil and natural gas reservoirs. The company assets consists of producing oil and natural gas properties located in Oklahoma, the Rockies, federal waters offshore Southern California, East Texas/North Louisiana and Eagle Ford.

Share on Social Networks: